• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过实施新辅助放化疗后的结构性重新分期和观察等待策略,避免不必要的主要直肠癌手术。

Avoiding Unnecessary Major Rectal Cancer Surgery by Implementing Structural Restaging and a Watch-and-Wait Strategy After Neoadjuvant Radiochemotherapy.

机构信息

Department of Gastroenterology and Hepatology, Isala Hospital, Zwolle, The Netherlands.

Department of Surgery, Isala Hospital, Zwolle, The Netherlands.

出版信息

Ann Surg Oncol. 2021 May;28(5):2811-2818. doi: 10.1245/s10434-020-09192-0. Epub 2020 Nov 10.

DOI:10.1245/s10434-020-09192-0
PMID:33170456
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8043907/
Abstract

BACKGROUND

Pathologic complete response (pCR) after neoadjuvant chemoradiotherapy (nCRT) is found in 15-20% of patients with locally advanced rectal cancer. A watch-and-wait (W&W) strategy has been introduced as an alternative strategy to avoid surgery for selected patients with a clinical complete response at multidisciplinary response evaluation. The primary aim of this study was to evaluate the efficacy of the multidisciplinary response evaluation by comparing the proportion of patients with pCR since the introduction of the structural response evaluation with the period before response evaluation.

METHODS

This retrospective cohort study enrolled patients with locally advanced rectal cancer who underwent nCRT between January 2009 and May 2018, categorizing them into cohort A (period 2009-2015) and cohort B (period 2015-2018). The patients in cohort B underwent structural multidisciplinary response evaluation with the option of the W&W strategy. Proportion of pCR (ypT0N0), time-to-event (pCR) analysis, and stoma-free survival were evaluated in both cohorts.

RESULTS

Of the 259 patients in the study, 21 (18.4%) in cohort A and in 8 (8.7%) in cohort B had pCR (p = 0.043). Time-to-event analysis demonstrated a significant pCR decline in cohort B (p < 0.001). The stoma-free patient rate was 24% higher in cohort B (p < 0.001).

CONCLUSION

Multidisciplinary clinical response evaluation after nCRT for locally advanced rectal cancer led to a significant decrease in unnecessary surgery for the patients with a complete response.

摘要

背景

新辅助放化疗(nCRT)后病理完全缓解(pCR)在局部晚期直肠癌患者中占 15-20%。对于多学科反应评估时临床完全缓解的选择患者,已经引入了一种观察等待(W&W)策略作为替代手术的策略。本研究的主要目的是通过比较结构反应评估引入前后 pCR 患者的比例,来评估多学科反应评估的疗效。

方法

这项回顾性队列研究纳入了 2009 年 1 月至 2018 年 5 月间接受 nCRT 的局部晚期直肠癌患者,将其分为队列 A(2009-2015 年)和队列 B(2015-2018 年)。队列 B 中的患者接受了结构多学科反应评估,并可选择 W&W 策略。在两个队列中评估了 pCR(ypT0N0)的比例、时间事件(pCR)分析和无造口生存。

结果

在 259 名患者中,队列 A 中有 21 例(18.4%)和队列 B 中有 8 例(8.7%)发生了 pCR(p=0.043)。时间事件分析表明,队列 B 中的 pCR 显著下降(p<0.001)。队列 B 中无造口患者的比例增加了 24%(p<0.001)。

结论

局部晚期直肠癌 nCRT 后的多学科临床反应评估导致完全缓解患者不必要手术的显著减少。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b3/8043907/2907120c1d3f/10434_2020_9192_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b3/8043907/6b4c6ee04bb1/10434_2020_9192_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b3/8043907/2907120c1d3f/10434_2020_9192_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b3/8043907/6b4c6ee04bb1/10434_2020_9192_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b3/8043907/2907120c1d3f/10434_2020_9192_Fig2_HTML.jpg

相似文献

1
Avoiding Unnecessary Major Rectal Cancer Surgery by Implementing Structural Restaging and a Watch-and-Wait Strategy After Neoadjuvant Radiochemotherapy.通过实施新辅助放化疗后的结构性重新分期和观察等待策略,避免不必要的主要直肠癌手术。
Ann Surg Oncol. 2021 May;28(5):2811-2818. doi: 10.1245/s10434-020-09192-0. Epub 2020 Nov 10.
2
[Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].巩固性新辅助治疗或全新辅助治疗后低位直肠癌的保直肠手术:初步报告
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Mar 25;23(3):281-288. doi: 10.3760/cma.j.cn.441530-20200228-00096.
3
["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons].直肠癌新辅助治疗后的“观察与等待”策略:中国外科医生的认知、态度及治疗选择现状调查
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Jun 25;22(6):550-559. doi: 10.3760/cma.j.issn.1671-0274.2019.06.008.
4
[Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy].[新辅助治疗后临床完全缓解的局部晚期直肠癌患者中观察等待策略与全直肠系膜切除术的长期疗效比较]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Mar 25;23(3):266-273. doi: 10.3760/cma.j.cn.441530-20200224-00081.
5
[Application value of colonoscopic assessment in "watch and wait" strategy for mid-lower rectal cancer after neoadjuvant chemoradiotherapy].结肠镜评估在中低位直肠癌新辅助放化疗后“观察等待”策略中的应用价值
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Jul 25;22(7):648-655. doi: 10.3760/cma.j.issn.1671-0274.2019.07.009.
6
[Rational evaluation of the complete response after neoadjuvant therapy in locally advanced mid-low rectal cancer: the pros and cons of "watch and wait" strategy].[局部进展期中低位直肠癌新辅助治疗后完全缓解的合理评估:“观察等待”策略的利弊]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Jun 25;22(6):507-513. doi: 10.3760/cma.j.issn.1671-0274.2019.06.002.
7
[Application of imaging diagnosis in watch and wait strategy for locally advanced rectal cancer patients after neoadjuvant therapy].影像学诊断在局部晚期直肠癌患者新辅助治疗后观察等待策略中的应用
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Mar 25;23(3):243-247. doi: 10.3760/cma.j.cn.441530-20200224-00078.
8
[Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center].[新辅助放化疗后直肠癌的观察等待策略或器官保留结果:来自单一癌症中心的35例报告]
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Apr 25;20(4):417-424.
9
Rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy, surgery, or "watch and wait".经新辅助放化疗、手术或“观察等待”后出现完全临床缓解的直肠癌
Int J Colorectal Dis. 2016 Feb;31(2):413-9. doi: 10.1007/s00384-015-2460-y. Epub 2015 Nov 25.
10
[Guiding significance of pathological diagnosis in watch and wait strategy for locally advanced rectal cancer patients after neoadjuvant therapy].[病理诊断在局部晚期直肠癌患者新辅助治疗后观察等待策略中的指导意义]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Mar 25;23(3):248-251. doi: 10.3760/cma.j.cn.441530-20200224-00079.

引用本文的文献

1
Personalized medicine for locally advanced rectal cancer: five years of complete clinical response after neoadjuvant radiochemotherapy-a case report with a literature review.局部晚期直肠癌的个性化医疗:新辅助放化疗后五年完全临床缓解——一例病例报告并文献复习
Front Surg. 2024 Mar 25;11:1385378. doi: 10.3389/fsurg.2024.1385378. eCollection 2024.
2
Organ sparing to cure stage IV rectal cancer: A case report and review of literature.保留器官以治愈IV期直肠癌:一例病例报告及文献综述
World J Gastrointest Surg. 2023 Nov 27;15(11):2619-2626. doi: 10.4240/wjgs.v15.i11.2619.
3
The "Immunoscore" in rectal cancer: could we search quality beyond quantity of life?
直肠癌的“免疫评分”:我们能否在追求生命数量的同时追求生命质量?
Oncotarget. 2022 Jan 5;13:18-31. doi: 10.18632/oncotarget.28100. eCollection 2022.
4
Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data.基于重建的个体患者数据的新辅助治疗后直肠癌不同肿瘤退缩分级和病理完全缓解的生存景观。
BMC Cancer. 2021 Nov 13;21(1):1214. doi: 10.1186/s12885-021-08922-1.
5
Intensifying Neoadjuvant Therapy for Rectal Cancers Towards Watchful Waiting.强化直肠癌新辅助治疗以实现观察等待
Ann Surg Oncol. 2021 Jul;28(7):4062-4063. doi: 10.1245/s10434-020-09512-4. Epub 2021 Jan 22.
6
Reply to "Intensifying Neoadjuvant Therapy for Rectal Cancers Towards Watchful Waiting," by Chakrabarti, Deep, et al.
Ann Surg Oncol. 2021 Jul;28(7):4064-4065. doi: 10.1245/s10434-020-09513-3. Epub 2021 Jan 10.